Exhaled Breath MicroRNAs As Non-Invasive Biomarkers Of Lung Cancer Risk

Author(s):  
Simon D. Spivack ◽  
Miao Shi ◽  
Weiguo Han ◽  
Steven Keller
2022 ◽  
Vol 11 ◽  
Author(s):  
Lan-Wei Guo ◽  
Zhang-Yan Lyu ◽  
Qing-Cheng Meng ◽  
Li-Yang Zheng ◽  
Qiong Chen ◽  
...  

BackgroundAbout 15% of lung cancers in men and 53% in women are not attributable to smoking worldwide. The aim was to develop and validate a simple and non-invasive model which could assess and stratify lung cancer risk in non-smokers in China.MethodsA large-sample size, population-based study was conducted under the framework of the Cancer Screening Program in Urban China (CanSPUC). Data on the lung cancer screening in Henan province, China, from October 2013 to October 2019 were used and randomly divided into the training and validation sets. Related risk factors were identified through multivariable Cox regression analysis, followed by establishment of risk prediction nomogram. Discrimination [area under the curve (AUC)] and calibration were further performed to assess the validation of risk prediction nomogram in the training set, and then validated by the validation set.ResultsA total of 214,764 eligible subjects were included, with a mean age of 55.19 years. Subjects were randomly divided into the training (107,382) and validation (107,382) sets. Elder age, being male, a low education level, family history of lung cancer, history of tuberculosis, and without a history of hyperlipidemia were the independent risk factors for lung cancer. Using these six variables, we plotted 1-year, 3-year, and 5-year lung cancer risk prediction nomogram. The AUC was 0.753, 0.752, and 0.755 for the 1-, 3- and 5-year lung cancer risk in the training set, respectively. In the validation set, the model showed a moderate predictive discrimination, with the AUC was 0.668, 0.678, and 0.685 for the 1-, 3- and 5-year lung cancer risk.ConclusionsWe developed and validated a simple and non-invasive lung cancer risk model in non-smokers. This model can be applied to identify and triage patients at high risk for developing lung cancers in non-smokers.


2019 ◽  
Author(s):  
A Tufman ◽  
S Schneiderbauer ◽  
D Kauffmann-Guerrero ◽  
F Manapov ◽  
C Schneider ◽  
...  

2013 ◽  
Vol 12 (6) ◽  
pp. 1281-1285 ◽  
Author(s):  
Tiberius Dicu ◽  
Doina Todea ◽  
Constantin Cosma ◽  
Loredana Rosca ◽  
Alexandra Cucos Dinu ◽  
...  

2018 ◽  
Vol 238 (5) ◽  
pp. 395-421 ◽  
Author(s):  
Nicolas R. Ziebarth

Abstract This paper empirically investigates biased beliefs about the risks of smoking. First, it confirms the established tendency of people to overestimate the lifetime risk of a smoker to contract lung cancer. In this paper’s survey, almost half of all respondents overestimate this risk. However, 80% underestimate lung cancer deadliness. In reality, less than one in five patients survive five years after a lung cancer diagnosis. Due to the broad underestimation of the lung cancer deadliness, the lifetime risk of a smoker to die of lung cancer is underestimated by almost half of all respondents. Smokers who do not plan to quit are significantly more likely to underestimate this overall mortality risk.


Epigenetics ◽  
2021 ◽  
pp. 1-16
Author(s):  
Marina Laplana ◽  
Matthias Bieg ◽  
Christian Faltus ◽  
Svitlana Melnik ◽  
Olga Bogatyrova ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document